Company News

Mary Kay Presents Research on Topical Treatment for Droopy Eyes

Extracts targeted three contributors to the effect: dermal matrix degradation, weakening of the upper eyelid retractor and shifting of upper eyelid fat pads

Author Image

By: Christine Esposito

Editor-in-Chief

At the 51st annual European Society for Dermatological Research (ESDR) Meeting held in Amsterdam in September, Mary Kay presented new findings from its ongoing research focused on the biology of skin aging, including exploration of the changes over time that impact the upper eyelid.

Over time, the upper eyelid contours begin to sag, leading to a droopy or hooded appearance. Currently, only in-office options have been shown to significantly improve the appearance of droopy lids.

Geetha Kalahasti, associate principal scientist, upstream research, clinical and scientific credentialing at Mary Kay, shared the results of a clinical study that evaluated the effectiveness of a cosmetic formulation containing botanical extracts as a topical solution to treat droopy lids.

The botanical extracts targeted three main components that contribute to the effect: dermal matrix degradation, weakening of the upper eyelid retractor, and shifting of upper eyelid fat pads. The findings showed significant improvement in eyelid droopiness and contouring, providing a promising at-home cosmetic solution to the droopy eye concern. Two independent board-certified dermatologists evaluated the clinical images and confirmed the results to be compelling.

“Women are seeking more advanced at-home beauty treatment options and our Upstream Innovation team is meeting this need by designing new products that provide compelling skin benefits. This is just one of the many ways we meet and exceed consumer expectations,” added Dr. Lucy Gildea, chief innovation officer, product and science at Mary Kay.

Keep Up With Our Content. Subscribe To Happi Newsletters